|Bid||517.03 x 900|
|Ask||517.80 x 1200|
|Day's range||512.00 - 524.73|
|52-week range||455.23 - 706.95|
|Beta (5Y monthly)||0.95|
|PE ratio (TTM)||59.51|
|Earnings date||02 Feb 2022|
|Forward dividend & yield||N/A (N/A)|
|1y target est||706.17|
Following the partnership between IDEXX (IDXX) and PetDx , the test is likely to be available later in January to all veterinary customers of IDXX in the United States and Canada.
Distributor purchasing dynamics have an impact on IDEXX's (IDXX) reported sales of CAG products.
Idexx Laboratories (IDXX) closed at $661.32 in the latest trading session, marking a +0.86% move from the prior day.